Silvanus Bevan
Co-founder 1715Background
Silvanus Bevan opened a small pharmacy at Plough Court in London in 1715, establishing an enterprise that would accumulate over three centuries of continuous operational history. His decision to focus on compounding high-quality herbal remedies and tinctures, rather than the more common patent medicines of the era, established a tradition of scientific rigor that would define the company's approach to pharmaceutical manufacturing for the next three hundred years.
Role at GSK plc
GSK possesses a deep, corporate lineage, the result of a series of historic mergers, but tracing its most foundational roots to a small, pioneering apothecary in New Zealand and an innovative London pharmacy. The modern conglomerate (GlaxoSmithKline) was formed in 2000 through the mega-merger of Glaxo Wellcome and SmithKline Beecham, combining centuries of pharmaceutical history. The 'Glaxo' lineage is unique; it was founded in 1904 not in London, but in Bunnythorpe, New Zealand, by Joseph Nathan. Nathan was a Londoner who immigrated to New Zealand and built a trading business. He realized that the surplus of New Zealand milk could be dried into powder and exported as baby food. He named this successful product 'Glaxo.' The company eventually relocated its headquarters back to London and pivoted into pharmaceuticals, achieving foundational success with the mass production of penicillin during World War II. The 'SmithKline' lineage traces back even further, to 1830 in Philadelphia, Pennsylvania, when John K. Smith opened a successful drugstore. His company eventually merged with Mahlon Kline's wholesale business. The 'Beecham' lineage dates back to 1842 in England, when Thomas Beecham began selling quantities of his famous, lucrative laxative 'Beecham's Pills' (essentially inventing modern patent medicine marketing). Over a century and a half, these disparate, successful operations executed relentless consolidations. They transitioned from selling baby food, laxatives, and wholesale herbs into building the complex, modern R&D laboratories that produced blockbusters like Zantac (the world's first billion-dollar drug), establishing the globe-spanning architecture of modern GSK.